Evolent Health, Inc. (EVH)
NYSE: EVH · Real-Time Price · USD
4.180
-0.090 (-2.11%)
At close: May 8, 2026, 4:00 PM EDT
4.220
+0.040 (0.96%)
After-hours: May 8, 2026, 7:26 PM EDT

Evolent Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4704461,3113,7622,8072,469
Market Cap Growth
-55.64%-65.96%-65.14%34.01%13.70%82.57%
Enterprise Value
1,3141,2432,0254,3693,0732,400
Last Close Price
4.184.0011.2533.0328.0827.67
PE Ratio
--0.79-13.89-25.80-140.40-62.89
Forward PE
14.5116.8813.6638.4044.32-
PS Ratio
0.250.240.511.922.082.72
PB Ratio
1.191.081.313.523.273.56
P/TBV Ratio
1.201.101.293.443.063.43
P/FCF Ratio
79.7893.88-213.9933.04-56.24179.36
P/OCF Ratio
14.1211.4969.8826.38-242.9663.71
EV/Sales Ratio
0.700.660.792.222.272.64
EV/EBITDA Ratio
17.67-4.2226.0083.6843.39136.17
EV/EBIT Ratio
--3.03-50.02-61.35843.84-56.59
EV/FCF Ratio
222.90261.36-330.4538.38-61.57174.38
Debt / Equity Ratio
2.462.350.690.590.550.39
Debt / EBITDA Ratio
-3.22-3.369.1612.356.7215.91
Debt / FCF Ratio
706.40208.14-116.465.66-9.5420.38
Net Debt / Equity Ratio
2.071.960.550.410.32-0.09
Net Debt / EBITDA Ratio
-2.68-2.767.068.393.86-3.49
Net Debt / FCF Ratio
587.40170.71-89.783.85-5.48-4.47
Asset Turnover
1.000.840.980.870.840.65
Quick Ratio
1.261.270.810.971.061.06
Current Ratio
1.321.310.851.011.101.18
Return on Equity (ROE)
-122.77%-75.47%-5.96%-11.73%-2.41%-4.61%
Return on Assets (ROA)
-22.16%-18.46%-1.52%-1.77%0.07%-3.09%
Return on Invested Capital (ROIC)
-26.84%-21.99%-1.80%-2.20%0.10%-5.05%
Return on Capital Employed (ROCE)
-27.83%-24.54%-2.11%-4.20%0.31%-4.37%
Earnings Yield
-113.53%-126.75%-7.20%-3.88%-0.71%-1.59%
FCF Yield
1.25%1.07%-0.47%3.03%-1.78%0.56%
Buyback Yield / Dilution
1.41%0.41%-3.08%-18.73%-8.87%-1.34%
Total Shareholder Return
1.41%0.41%-3.08%-18.73%-8.87%-1.34%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q